Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
The Big Picture: Where Tirzepatide Fits Among Weight Loss Medications Today there are six FDA-approved medications most commonly prescribed for chronic weight management: Tirzepatide (brand name Zepbound) weekly injection, FDA-approved for weight management in November 20234 Semaglutide (brand names Wegovy and Ozempic) weekly injection Liraglutide (brand name Saxenda) daily injection Phentermine (often combined with topiramate as Qsymia) daily oral pill Naltrexone-bupropion (brand name Contrave) daily oral pill Orlistat (brand names Xenical and Alli) oral capsule with meals In large clinical trials, the average percent body weight lost over 1218 months looks roughly like this:[1][1] Tirzepatide: about 20% Semaglutide: about 14% Phentermine/topiramate: about 9% Liraglutide: about 5% Naltrexone-bupropion: about 5% Orlistat: about 3% Tirzepatide is, on paper, the most effective
Treatment includes correcting identified nutritional deficiencies through supplementation and, in some cases, topical minoxidil
(PubMed) Kuo YM, Hayflick SJ, Gitschier J
Anti-emetic medications are generally not recommended as first-line treatment, as most nausea resolves with dietary adjustments and time
It acts as a GLP-1 receptor agonist, mimicking the GLP-1 hormone to control appetite and insulin release
US$ 27.89
US$ 29.44
US$ 28.43
US$ 25.52
US$ 26.90
